speakers general information/organization
TRANSCRIPT
General Information/Organization
Scientifi c LeadershipProf. Dr. P. PisoProf. Dr. H. J. Schlitt
Congress VenueUniversity Hospital of RegensburgMinor Lecture Hall
Congress SecretaryIrmgard ScherueblUniversity Hospital Franz-Josef-Strauß-Allee 11, 93053 Regensburg, GermanyPhone +49 941 944 6837Fax +49 941 944 6838e-mail [email protected] http://www.uniklinikum-regensburg.de/
Registration fee: 150 € (both days) 110 € (friday) 75 € (saturday)Bavarian evening: September 18, 2009, Dinner charges 45 €
Payment via Bank account:Klinikum RegensburgBank code 750 500 00Account No. 780 010 500IBAN-Nr. DE52750500000780010500Swift-Code BYLADEM1RBGProject No. 374 42 34 (please quote)
Hotel AccomodationTourist Offi ce Regensburg, Altes RathausPhone +49(0)941 507 4410Fax +49(0)941 507 4419e-mail [email protected] www.regensburg.de
FortbildungspunkteBLAEK 20 Punkte
Speakers
Dr. Dirk ArnoldUniversitätsklinikum HalleProf. Dr. David L. BartlettUniversity of Pittsburgh, UPMC Cancer Pavillion, USAProf. Dr. Dennis S. ChiMemorial Sloan-Kettering Cancer Center, New York, USADr. Marcello DeracoInstuto Nazionali Tumori Milano, ItalyDr. Jesus EsquivelSt. Agnes Hospital, Baltimore, USAProf. Dr. Alfredo GarofaloNational Cancer Center Regina Elena, Roma, ItalyProf. Dr. Olivier GlehenCentre Hospitalier et Univ. Lyon, Pierre Benite cedex, FranceDr. Santiago Gonzalez-MorenoCentro Oncologico MD Anderson, Madrid, SpainDr. Philipp HarterDr. Horst-Schmidt-Kliniken GmbH, WiesbadenProf. Dr. Markus M. Heiss Krankenhaus Merheim, KölnProf. Dr. C. William HelmUniversity of Louisville, USADr. Felix HilpertUniversitätsklinikum Schleswig-Holstein, Campus KielProf. Dr. Joachim JähneDiakoniekrankenhaus Henriettenstiftung, HannoverProf. Dr. Alfred KönigsrainerUniversitätsklinik für Allgemeine Viszeral-und Transplantationschirurgie, TübingenProf. Dr. Björn LampeFlorence-Nightingale-Krankenhaus, DüsseldorfProf. Dr. Karl Heinz LinkAsklepios Paulinen Klinik, WiesbadenProf. Dr. Haile MathemeUppsala University, SwedenPD Dr. Markus MoehlerUniversitätsklinikum MainzDr. Aviram NissanHadassah University Mount Scopus, Jerusalem, IsraelProf. Dr. Olaf OrtmannCaritas KH St. Josef, RegensburgProf. Dr. Pompiliu PisoUniversitätsklinikum RegensburgProf. Dr. Dr. h. c. Peter M. SchlagRobert Rössle Klinik Charité Campus, BerlinProf. Dr. Hans J. SchlittUniversitätsklinikum RegensburgDr. Oliver ZivanovicUniversitätsfrauenklinik Bonn
Guest Speakers:DL Bartlett, Pittsburgh;
D Chi, New York;M Deraco, Milano;
J Esquivel, Baltimore;A Garofalo, Roma;O Glehen, Lyon;
S Gonzalez-Moreno, Madrid;W Helm, Louisville;
H Mahteme, Uppsala;A Nissan, Jerusalem
Scientific Leadership:P Piso, HJ Schlitt, Regensburg
University of Regensburg
September 18-19, 2009
Regensburg, GermanyRegensburg, Germany
4thInternational Symposium
on Peritoneal Carcinomatosis
Faltblatt Peritoneum.indd 1 12.06.2009 11:39:27
Program
Friday, 18.09.200908:30 – 09:00 Welcome ceremony
P. Piso Opening lecturesChairmen: HJ Schlitt, J Esquivel09:00 – 09:30 Objective barriers to making cytoreductive
surgery and hyperthermic intraperitoneal chemotherapy standard of care J Esquivel
09:30 – 10:00 How to get CRS and HIPEC into the guide-lines – the French success O Glehen
10:00 – 10:30 Patients selection for peritoneal carcinoma-tosis arising from colorectal cancer S Gonzalez-Moreno
10:30 – 11:00 Coffee Break and sponsor visiting
Colorectal cancerChairmen: KH Link, A Nissan11:00 – 11:15 Guidelines for treatment of metastastic
colorectal cancer in Germany D Arnold
11:15– 11:30 The German Phase II study on PC from colo-rectal cancer P. Piso
11:30 – 11:45 Ideal study on multimodality approach for PC A Nissan
11:45 – 12:30 Free papers12:30 – 14:00 Lunch and sponsor visiting
Ovarian cancer IChairmen: P Piso, D Chi14:00 – 14:30 German guidelines for treatment of primary
and/or recurrent ovarian cancer with perito-neal carcinomatosis F Hilpert
14:30 – 14:50 Ovarian Team – a multidisciplinary approach with advanced cytoreductive surgery D Chi
14:50 – 15:00 GYN-Oncology training at the Memorial Sloan Kettering – my lessons O Zivanovic
15:00 – 15:30 What about intraperitoneal chemotherapy ? Pro: D Chi / Con: O Ortmann
Dear colleagues,
cytoreductive surgery combined with hyperther-mic intraperitoneal and systemic chemotherapy represents a valid strategy for selected patients. A lot has been learned over the last years. We managed to reduce perioperative morbidity and mortality, and have achieved a consensus regar-ding different aspects of the treatment. This sym-posium will focused on many practical details, as well as several aspects of preclinical and clinical research, e.g. quality of life, imaging or molecu-lar diagnosis.More than in the years before, GYN malignomas will be the main topic of this meeting.
Looking forward to meet you in Regensburg, we remain with best regards
H. J. Schlitt P. Piso
Under the patronage of- CAO der Deutschen Gesellschaft für Viszeralchirurgie- Tumorzentrum Regensburg- AIO (Arbeitsgemeinschaft Internistische Onkologie- AGO (Arbeitsgemeinschaft Gynäkologische Onkologie (AGO-Ovar)
Program
15:30 – 16:00 Coffee Break and sponsor visiting
Ovarian cancer IIChairmen: J Jaehne, W Helm16:00 – 16:30 Hyperthermic intraperitoneal chemo-
therapy for ovarian cancer W Helm
16:30 – 16:45 Role of complete cytoreduction for recurrent ovarian cancer P Harter
16:45 – 17:00 Pelvic exenteration for recurrent ovarian cancer B Lampe
19:00 Bavarian evening
Saturday, 19.09.2009 Gastric cancerChairmen: PM Schlag, A Garofalo09:00 – 09:30 National guidelines of gastric cancer: how
do they comment on diagnosis and treat-ment of peritoneal carcinosis ? M Moehler
09:30 – 10:00 Selection of patients with gastric cancer and PC for CRS and HIPEC O Glehen
10:00 – 10:15 German GASTRIPEC trial PM Schlag
10:15 – 10:30 Adjuvant intraperitoneal immunotherapy MM Heiss
10:30 – 11:00 Coffee Break and sponsor visiting
Malignant peritoneal mesotheliomaChairmen: A Koenigsrainer, DL Bartlett11:00 – 11:30 CRS and HIPEC – UMPC data
DL Bartlett11:30 – 12:00 CRS and HIPEC – Italian data
M Deraco12:00 – 13:00 Free papers13:00 – 13:30 Future perspectives and announcement of
the Uppsala meeting 2009 H Mahteme
following Lunch break
Main Sponsors:ThermaSolutionsCovidien Deutschland GmbHFresenius Biotech GmbH Merck Pharma GmbH
Sponsors:Amgen GmbHBaxter Deutschland GmbHEFSKardialgut GmbHMSD Sharp & Dohme GmbH
Nycomed Deutschland GmbHRanD S.r.l.Roche Phama AGKarl Storz GmbH & Co. KG
Call for [email protected]: July, 1 2009
Faltblatt Peritoneum.indd 2 12.06.2009 11:39:28